Allen Ebens

4.4k total citations
31 papers, 1.7k citations indexed

About

Allen Ebens is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Allen Ebens has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Oncology. Recurrent topics in Allen Ebens's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Cancer Mechanisms and Therapy (6 papers) and CAR-T cell therapy research (6 papers). Allen Ebens is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Cancer Mechanisms and Therapy (6 papers) and CAR-T cell therapy research (6 papers). Allen Ebens collaborates with scholars based in United States, United Kingdom and China. Allen Ebens's co-authors include Tariq Enver, S Lawrence Zipursky, Thalia Papayannopoulou, Natacha Raich, Frank Costantini, Barbara A. Barres, Marc Tessier‐Lavigne, E. David Leonardo, Friedhelm Bladt and Katja Brose and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Allen Ebens

29 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allen Ebens United States 16 974 464 226 217 217 31 1.7k
Sheila Harroch France 28 1.2k 1.3× 334 0.7× 406 1.8× 72 0.3× 149 0.7× 40 2.2k
Marjo Simonen Switzerland 14 1.3k 1.4× 734 1.6× 287 1.3× 198 0.9× 66 0.3× 17 2.2k
F S Walsh United Kingdom 10 1.1k 1.1× 451 1.0× 197 0.9× 57 0.3× 115 0.5× 14 1.8k
Mohamed Abdouh Canada 28 1.3k 1.3× 146 0.3× 397 1.8× 275 1.3× 121 0.6× 51 1.9k
Dongeun Park South Korea 23 1.2k 1.2× 348 0.8× 166 0.7× 58 0.3× 109 0.5× 57 1.8k
K Letwin Canada 11 1.0k 1.0× 226 0.5× 222 1.0× 59 0.3× 125 0.6× 12 1.4k
Mordechai Anafi Canada 13 628 0.6× 224 0.5× 199 0.9× 123 0.6× 58 0.3× 16 1.1k
Joseph Pearlberg United States 20 1.5k 1.6× 340 0.7× 740 3.3× 98 0.5× 272 1.3× 34 2.3k
Donald A. Bergstrom United States 18 1.6k 1.6× 104 0.2× 402 1.8× 273 1.3× 295 1.4× 44 2.2k
David R. Kaplan United States 17 1.9k 2.0× 191 0.4× 549 2.4× 78 0.4× 162 0.7× 24 2.5k

Countries citing papers authored by Allen Ebens

Since Specialization
Citations

This map shows the geographic impact of Allen Ebens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allen Ebens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allen Ebens more than expected).

Fields of papers citing papers by Allen Ebens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allen Ebens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allen Ebens. The network helps show where Allen Ebens may publish in the future.

Co-authorship network of co-authors of Allen Ebens

This figure shows the co-authorship network connecting the top 25 collaborators of Allen Ebens. A scholar is included among the top collaborators of Allen Ebens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allen Ebens. Allen Ebens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Fei, Caroline Tang, Xiaoyong Chen, et al.. (2024). Cathepsin B Nuclear Flux in a DNA-Guided “Antinuclear Missile” Cancer Therapy. ACS Central Science. 10(8). 1562–1572. 4 indexed citations
2.
Ho, Pui Yan, Zhen Zhang, Mark Hayes, et al.. (2021). Peptide nucleic acid–dependent artifact can lead to false-positive triplex gene editing signals. Proceedings of the National Academy of Sciences. 118(45). 7 indexed citations
3.
Zheng, Jing, Yonggang Sha, Oded Foreman, et al.. (2018). Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1/3 cascade. Cancer Letters. 440-441. 1–10. 14 indexed citations
4.
Wang, Xiaojing, Aleksandr Kolesnikov, Suzanne Tay, et al.. (2017). Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability. Journal of Medicinal Chemistry. 60(10). 4458–4473. 19 indexed citations
5.
6.
Hu, Huiyong, Xiaojing Wang, Jae H. Chang, et al.. (2015). Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(22). 5258–5264. 19 indexed citations
7.
Chen, Xiaocheng, Yvonne Chen, Mark S. Dennis, et al.. (2014). Pre-Clinical Characterization of T Cell-Dependent Bispecific Antibody Anti-CD79b/CD3 As a Potential Therapy for B Cell Malignancies. Blood. 124(21). 4507–4507. 3 indexed citations
8.
Munugalavadla, Veerendra, Sanjeev Mariathasan, Dionysos Slaga, et al.. (2013). The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma. Oncogene. 33(3). 316–325. 37 indexed citations
9.
Wang, Xiaojing, Steven Magnuson, Huiyong Hu, et al.. (2013). Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design. Bioorganic & Medicinal Chemistry Letters. 23(11). 3149–3153. 55 indexed citations
10.
Li, Congfen, Chikara Takahashi, Mahrukh Huseni, et al.. (2013). Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma. Journal of Translational Medicine. 11(1). 76–76. 8 indexed citations
11.
Elkins, Kristi, Bing Zheng, MaryAnn Go, et al.. (2012). FcRL5 as a Target of Antibody–Drug Conjugates for the Treatment of Multiple Myeloma. Molecular Cancer Therapeutics. 11(10). 2222–2232. 69 indexed citations
12.
Burington, Bart, Thomas Januario, Jeffrey Lau, et al.. (2008). CD40 pathway activation status and germinal B-cell identity are predictive of response to anti-CD40 (SGN-40) in preclinical NHL models. Clinical Cancer Research. 14. 1 indexed citations
13.
Polson, Andrew G., Fiona Bennett, Yvonne Chen, et al.. (2008). Development and Therapeutic Potential of an Anti-CD79b Antibody-Drug Conjugate, Anti-CD79b-Vc-MMAE, for the Treatment of Non-Hodgkin’s Lymphoma. Blood. 112(11). 2618–2618. 4 indexed citations
14.
Kunkel, Eric J., Allen Ebens, Evangelos Hytopoulos, et al.. (2004). An integrative biology approach for analysis of drug action in models of human vascular inflammation. The FASEB Journal. 18(11). 1279–1281. 63 indexed citations
15.
Xu, Xiaomei, Zhiliang Wu, Dat Nguyen, et al.. (1998). Human Semaphorin K1 Is Glycosylphosphatidylinositol-linked and Defines a New Subfamily of Viral-related Semaphorins. Journal of Biological Chemistry. 273(35). 22428–22434. 100 indexed citations
16.
Ebens, Allen, Katja Brose, E. David Leonardo, et al.. (1996). Hepatocyte Growth Factor/Scatter Factor Is an Axonal Chemoattractant and a Neurotrophic Factor for Spinal Motor Neurons. Neuron. 17(6). 1157–1172. 356 indexed citations
17.
Martin, Kathleen A., Burkhard Poeck, Helmut Roth, et al.. (1995). Mutations disrupting neuronal connectivity in the Drosophila visual system. Neuron. 14(2). 229–240. 72 indexed citations
18.
Ebens, Allen, Hideki Garren, Benjamin Cheyette, & S Lawrence Zipursky. (1993). The Drosophila anachronism locus: A glycoprotein secreted by glia inhibits neuroblast proliferation. Cell. 74(1). 15–27. 174 indexed citations
19.
Stamatoyannopoulos, G, Natacha Raich, Allen Ebens, et al.. (1990). Analysis of Human γ‐To‐β Switching in Transgenic Micea. Annals of the New York Academy of Sciences. 612(1). 127–133. 1 indexed citations
20.
Enver, Tariq, et al.. (1990). Developmental regulation of human fetal-to-adult globin gene switching in transgenic mice. Nature. 344(6264). 309–313. 322 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheila Harroch Breakdown of academic impact, for papers by Marjo Simonen Breakdown of academic impact, for papers by F S Walsh Breakdown of academic impact, for papers by Mohamed Abdouh Breakdown of academic impact, for papers by Dongeun Park Breakdown of academic impact, for papers by K Letwin Breakdown of academic impact, for papers by Mordechai Anafi Breakdown of academic impact, for papers by Joseph Pearlberg Breakdown of academic impact, for papers by Donald A. Bergstrom Breakdown of academic impact, for papers by David R. Kaplan
Rankless by CCL
2026